Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis

Antioxidants and Redox Signaling

Volumn 23, Issue 16, 2015, Pages 1255-1269

  Pulli, Benjamin ^a   Ali, Muhammad ^a   Iwamoto, Yoshiko ^a   Zeller, Matthias W G ^a   Schob, Stefan ^a   Linnoila, Jenny J ^a   Chen, John W ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 1 A1; CXCL1 CHEMOKINE; HYPOCHLOROUS ACID; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOGEN ACTIVATED PROTEIN KINASE; MYELOPEROXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CYTOKINE; PEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LIVER CELL; LIVER CELL DAMAGE; LIVER FIBROSIS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; MONOCYTE; MOUSE; NEUTROPHIL COUNT; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; STELLATE CELL; UPREGULATION; ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; BIOSYNTHESIS; BONE MARROW CELL; CELL COMMUNICATION; CELL MEMBRANE PERMEABILITY; COMPLICATION; DISEASE MODEL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INTRACELLULAR MEMBRANE; KNOCKOUT MOUSE; LIVER CIRRHOSIS; LIVER MITOCHONDRION; METABOLISM; NEUTROPHIL; PATHOLOGY;

ANIMALS; APOPTOSIS; CELL COMMUNICATION; CELL MEMBRANE PERMEABILITY; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GENE EXPRESSION; HEPATIC STELLATE CELLS; HEPATOCYTES; INTRACELLULAR MEMBRANES; LIVER CIRRHOSIS; MICE; MICE, KNOCKOUT; MITOCHONDRIA, LIVER; MODELS, BIOLOGICAL; MYELOID CELLS; NEUTROPHILS; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; PEROXIDASE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84946100211     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.6108     Document Type: Article

References (56)

1. Adams LA and Angulo P. Recent concepts in non-alcoholic fatty liver disease. Diabet Med 22: 1129-1133, 2005.
2. Alano CC, Ying W, and Swanson RA. Poly(ADP-ribose) polymerase-1-mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition. J Biol Chem 279: 18895-18902, 2004.
3. Amanzada A, Malik IA, Nischwitz M, Sultan S, Naz N, and Ramadori G. Myeloperoxidase and elastase are only expressed by neutrophils in normal and in inflamed liver. Histochem Cell Biol 135: 305-315, 2011.
4. Bachem MG, Meyer D, Melchior R, Sell KM, and Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 89: 19-27, 1992.
5. Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J, Qian T, Schoonhoven R, Hagedorn CH, Lemasters JJ, and Brenner DA. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112: 1383-1394, 2003.
6. Bellentani S and Marino M. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann Hepatol 8 Suppl 1: S4-S8, 2009.
7. Blom KG, Qazi MR, Matos JB, Nelson BD, DePierre JW, and Abedi-Valugerdi M. Isolation of murine intrahepatic immune cells employing a modified procedure for mechanical disruption and functional characterization of the B, T and natural killer T cells obtained. Clin Exp Immunol 155: 320-329, 2009.
8. Carmona-Cuenca I, Herrera B, Ventura JJ, Roncero C, Fernandez M, and Fabregat I. EGF blocks NADPH oxidase activation by TGF-beta in fetal rat hepatocytes, impairing oxidative stress, and cell death. J Cell Physiol 207: 322-330, 2006.
9. Chen JW, Querol Sans M, Bogdanov A, Jr., Weissleder R. Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. Radiology 240: 473-481, 2006.
10. Chen M, Zsengeller Z, Xiao CY, and Szabo C. Mitochondrial-to-nuclear translocation of apoptosis-inducing factor in cardiac myocytes during oxidant stress: potential role of poly(ADP-ribose) polymerase-1. Cardiovasc Res 63: 682-688, 2004.
11. Connolly MK, Bedrosian AS, Mallen-St Clair J, Mitchell AP, Ibrahim J, Stroud A, Pachter HL, Bar-Sagi D, Frey AB, and Miller G. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J Clin Invest 119: 3213-3225, 2009.
12. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, and Iredale JP. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115: 56-65, 2005.
13. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, and Kechagias S. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44: 865-873, 2006.
14. Fassio E, Alvarez E, Dominguez N, Landeira G, and Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 40: 820-826, 2004.
15. Forbes LV, Sjogren T, Auchere F, Jenkins DW, Thong B, Laughton D, Hemsley P, Pairaudeau G, Turner R, Eriksson H, Unitt JF, and Kettle AJ. Potent reversible inhibition of myeloperoxidase by aromatic hydroxamates. J Biol Chem 288: 36636-36647, 2013.
16. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88: 125-172, 2008.
17. Gabele E, Reif S, Tsukada S, Bataller R, Yata Y, Morris T, Schrum LW, Brenner DA, and Rippe RA. The role of p70S6K in hepatic stellate cell collagen gene expression and cell proliferation. J Biol Chem 280: 13374-13382, 2005.
18. Galli A, Svegliati-Baroni G, Ceni E, Milani S, Ridolfi F, Salzano R, Tarocchi M, Grappone C, Pellegrini G, Benedetti A, Surrenti C, and Casini A. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepatology 41: 1074-1084, 2005.
19. Gressner AM, Weiskirchen R, Breitkopf K, and Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci 7: d793-d807, 2002.
20. Gujral JS, Hinson JA, Farhood A, and Jaeschke H. NADPH oxidase-derived oxidant stress is critical for neutrophil cytotoxicity during endotoxemia. Am J Physiol Gastrointest Liver Physiol 287: G243-G252, 2004.
21. Han D, Hanawa N, Saberi B, and Kaplowitz N. Mechanisms of liver injury. III. Role of glutathione redox status in liver injury. Am J Physiol Gastrointest Liver Physiol 291: G1-G7, 2006.
22. Ho JS, Buchweitz JP, Roth RA, and Ganey PE. Identification of factors from rat neutrophils responsible for cytotoxicity to isolated hepatocytes. J Leukoc Biol 59: 716-724, 1996.
23. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol 77: 598-625, 2005.
24. Kleiner DE, Brunt EM, Van Natta M, Behling C, ContosMJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, and Nonalcoholic Steatohepatitis Clinical Research N. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321, 2005.
25. Kluwe J, Pradere JP, Gwak GY, Mencin A, De Minicis S, Osterreicher CH, Colmenero J, Bataller R, and Schwabe RF. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. Gastroenterology 138: 347-359, 2010.
26. Lanza F. Clinical manifestation of myeloperoxidase deficiency. J Mol Med (Berl) 76: 676-681, 1998.
27. Leo MA and Lieber CS. Hepatic vitamin A depletion in alcoholic liver injury. N Engl J Med 307: 597-601, 1982.
28. Marra F, Arrighi MC, Fazi M, Caligiuri A, Pinzani M, Romanelli RG, Efsen E, Laffi G, and Gentilini P. Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat. Hepatology 30: 951-958, 1999.
29. Maschmeyer P, Flach M, and Winau F. Seven steps to stellate cells. J Vis Exp 51: pii: 2710, 2011.
30. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, and McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116: 1413-1419, 1999.
31. Mello T, Nakatsuka A, Fears S, Davis W, Tsukamoto H, Bosron WF, and Sanghani SP. Expression of carboxylesterase and lipase genes in rat liver cell-types. Biochem Biophys Res Commun 374: 460-464, 2008.
32. Olaso E, Ikeda K, Eng FJ, Xu L, Wang LH, Lin HC, and Friedman SL. DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J Clin Invest 108: 1369-1378, 2001.
33. Pulli B, Ali M, Forghani R, Schob S, Hsieh KL, Wojtkiewicz G, Linnoila JJ, and Chen JW. Measuring myeloperoxidase activity in biological samples. PLoS One 8: e67976, 2013.
34. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T, and Group LS. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128: 1898-1906, 2005.
35. Reeves HL, Dack CL, Peak M, Burt AD, and Day CP. Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture. J Hepatol 32: 465-472, 2000.
36. Reif S, Lang A, Lindquist JN, Yata Y, Gabele E, Scanga A, Brenner DA, and Rippe RA. The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression. J Biol Chem 278: 8083-8090, 2003.
37. Reiniers MJ, van Golen RF, van Gulik TM, and Heger M. Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver. Antioxid Redox Signal 21: 1119-1142, 2014.
38. Rensen SS, Bieghs V, Xanthoulea S, Arfianti E, Bakker JA, Shiri-Sverdlov R, Hofker MH, Greve JW, and Buurman WA. Neutrophil-derived myeloperoxidase aggravates nonalcoholic steatohepatitis in low-density lipoprotein receptordeficient mice. PLoS One 7: e52411, 2012.
39. Rensen SS, Slaats Y, Nijhuis J, Jans A, Bieghs V, Driessen A, Malle E, Greve JW, and Buurman WA. Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am J Pathol 175: 1473-1482, 2009.
40. Rowell DL, Eckmann L, Dwinell MB, Carpenter SP, Raucy JL, Yang SK, and Kagnoff MF. Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion. Am J Physiol 273: G322-G332, 1997.
41. Rudolph V, Andrie RP, Rudolph TK, Friedrichs K, Klinke A, Hirsch-Hoffmann B, Schwoerer AP, Lau D, Fu X, Klingel K, Sydow K, Didie M, Seniuk A, von Leitner EC, Szoecs K, Schrickel JW, Treede H, Wenzel U, Lewalter T, Nickenig G, ZimmermannWH, Meinertz T, Boger RH, Reichenspurner H, Freeman BA, Eschenhagen T, Ehmke H, Hazen SL, Willems S, and Baldus S. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med 16: 470-474, 2010.
42. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, and Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378, 2003.
43. Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, and Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 37: 56-62, 2002.
44. Selloum L, Djelili H, Sebihi L, and Arnhold J. Scavenger effect of flavonols on HOCl-induced luminol chemiluminescence. Luminescence 19: 199-204, 2004.
45. Singh R and Czaja MJ. Regulation of hepatocyte apoptosis by oxidative stress. J Gastroenterol Hepatol 22 Suppl 1: S45-S48, 2007.
46. Szabo C, Ischiropoulos H, and Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6: 662-680, 2007.
47. Takehara T, Tatsumi T, Suzuki T, Rucker EB, 3rd, Hennighausen L, Jinushi M, Miyagi T, Kanazawa Y, and Hayashi N. Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. Gastroenterology 127: 1189-1197, 2004.
48. Theruvath TP, Snoddy MC, Zhong Z, and Lemasters JJ. Mitochondrial permeability transition in liver ischemia and reperfusion: role of c-Jun N-terminal kinase 2. Transplantation 85: 1500-1504, 2008.
49. Tomita K, Tamiya G, Ando S, Ohsumi K, Chiyo T, Mizutani A, Kitamura N, Toda K, Kaneko T, Horie Y, Han JY, Kato S, Shimoda M, Oike Y, Tomizawa M, Makino S, Ohkura T, Saito H, Kumagai N, Nagata H, Ishii H, and Hibi T. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 55: 415-424, 2006.
50. Ventura JJ, Cogswell P, Flavell RA, Baldwin AS, Jr., Davis RJ. JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes Dev 18: 2905-2915, 2004.
51. Ward J, Spath SN, Pabst B, Carpino PA, Ruggeri RB, Xing G, Speers AE, Cravatt BF, and Ahn K. Mechanistic characterization of a 2-thioxanthine myeloperoxidase inhibitor and selectivity assessment utilizing click chemistry-activitybased protein profiling. Biochemistry 52: 9187-9201, 2013.
52. Weltman MD, Farrell GC, and Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111: 1645-1653, 1996.
53. Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, and Diehl AM. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Hepatology 50: 1421-1430, 2009.
54. Yang L, Roh YS, Song J, Zhang B, Liu C, Loomba R, and Seki E. Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice. Hepatology 59: 483-495, 2014.
55. Zhang N, Francis KP, Prakash A, and Ansaldi D. Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of near-infrared nanoparticles. Nat Med 19: 500-505, 2013.
56. Zhao H, Kalivendi S, Zhang H, Joseph J, Nithipatikom K, Vasquez-Vivar J, and Kalyanaraman B. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic Biol Med 34: 1359-1368, 2003.